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ABSTRACT
SLX5 and SLX8 encode RING-finger proteins that
were previously identified based on their require-
ment for viability in yeast cells lacking Sgs1 DNA
helicase. Slx5 and Slx8 proteins are known to be
required for genome stability and to physically
interact in yeast extracts; however, their biochemi-
cal functions are unknown. To address this question
we purified and characterized recombinant Slx5 and
Slx8 proteins. Here we show that Slx5 and Slx8 form
a heterodimeric complex with double-stranded DNA
(dsDNA)-binding activity. Individually, only the Slx8
subunit displays this activity. Structure–function
studies indicate that the DNA-binding activity
requires only the N-terminal 160 amino acids of
Slx8, but not its C-terminal RING-finger domain.
Alleles of SLX8 that express the RING-finger domain
alone show almost complete complementation in
yeast indicating that this DNA-binding domain is not
essential for this in vivo function. Consistent with
these findings we show that Slx5 immunolocalizes
to the nucleus and that a portion of the Slx8 protein
co-fractionates with chromatin. These results sug-
gest that Slx5–Slx8 may act directly on DNA to
promote genome stability.
INTRODUCTION
The Sgs1 protein of budding yeast has been used as a model
system to understand how eukaryotic RecQ DNA helicases
function to maintain genome integrity. Loss of SGS1 has
been shown to result in increased rates of recombination,
chromosome loss and missegregation, and a decrease in
sporulation efﬁciency (1–3). These strains also display hyper-
sensitivity to a variety of DNA damaging agents such as
methyl methanesulfonate (MMS) and UV light, and they
are hypersensitive to the DNA synthesis inhibitor hydrox-
yurea (HU) (4,5). Genetic and biochemical evidence suggests
that the RecQ DNA helicases, such as Sgs1 and human BLM,
cooperate with DNA topoisomerase III (Top3) (3,6–8) and
the Rmi1/BLAP75 subunit (9–11) to resolve recombina-
tion intermediates in a pathway leading to non-crossovers.
Enzymatically, this could be accomplished using the RecQ
DNA helicase activity to branch-migrate double Holliday
junctions into a hemi-catenane structure that is decatenated
by Top3 (12–16).
The yeast system has been exploited to identify mutations
that are synthetically lethal with Sgs1 (17–19). SLX5 and
SLX8 encode proteins with a single RING-ﬁnger motif and
no obvious biochemical function. On their own, null muta-
tions in SLX5 or SLX8 produce nearly identical phenotypes.
Both slx5 and slx8 mutants display a heterogeneous colony
morphology consisting of a mixture of large and small colon-
ies with nibbled edges (19). Interestingly, this phenotype may
be related to a recently reported role of these genes in regu-
lating the SUMO pathway (20), since SUMO mutants were
originally characterized as having the nibbled phenotype
(21–24). The slx5 or slx8 mutants also share phenotypes
with sgs1 and top3 mutants such as reduced sporulation efﬁ-
ciency and hypersensitivity to prolonged exposure to HU
(19). Moreover, SLX5 and SLX8 act in the same pathway to
suppress gross chromosomal rearrangements (25). These phe-
notypes suggest that Slx5 and Slx8 may be required for DNA
repair and/or recombination like Sgs1–Top3–Rmi1. How-
ever, the synthetic lethality of sgs1 slx5 or sgs1 slx8 cells can-
not be suppressed by eliminating homologous recombination
as is observed in sgs1 mus81 or sgs1 srs2 strains (26–29).
Thus, at least one function of either Sgs1–Top3 or Slx5–
Slx8 must be upstream of, or independent of, homologous
recombination. Biochemically, the Slx5 and Slx8 proteins
were shown to co-immunoprecipitate from cell extracts
when overproduced in yeast, suggesting that the two proteins
may work as a complex (19). Such an idea would explain
their shared phenotypes.
Proteins homologous to Slx5 and Slx8 have been identiﬁed
in multiple species, suggesting that they are conserved
throughout eukaryotes [(19) and data not shown]. Both pro-
teins contain a single RING-ﬁnger motif of the C3HC4
type at their C-termini. RING ﬁngers are found in proteins
of diverse function and it has been suggested that this zinc-
binding domain may help to mediate DNA binding or
protein–protein interactions. Such may be the case in the
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gest class of RING-ﬁnger proteins is composed of ubiquitin
E3 ligases such as the well-known BRCA1, Mdm2 and
SCF proteins (30). More recently, variant RING-ﬁnger
domains (SP-RING) have been found in SUMO E3 ligases,
including the human PIAS1 and the yeast Siz1 and Siz2 pro-
teins (31–34). The presence of the RING-ﬁnger motif sug-
gests that Slx5 and Slx8 may interact with other proteins,
bind DNA, or function as ubiquitin or SUMO E3 ligases.
Based on the presumed role of Slx5 and Slx8 in DNA
metabolism, we tested the possibility that these proteins inter-
act with DNA. Slx5 and Slx8 were puriﬁed as recombinant
proteins and shown to form a stable complex when co-
expressed in Escherichia coli. An electrophoretic mobility
shift assay (EMSA) revealed that the Slx5–Slx8 complex
(Slx5–Slx8) binds double-stranded DNA (dsDNA), but not
single-stranded DNA (ssDNA), and that Slx8 mediates this
activity. Structure–function studies indicated that DNA bind-
ing by Slx8 was independent of its RING domain whereas
in vivo analysis conﬁrmed the essential function of the
RING domain. These studies represent the ﬁrst biochemical
characterization of Slx5 and Slx8 and show that these pro-
teins directly interact and bind DNA.
MATERIALS AND METHODS
Yeast strains and plasmids
The yeast strains used in this study are isogenic derivatives of
W303-1a (MATa ade2-1 ura3-52 his3-11, trp1-1 leu2-3,112
can1-100) (35). W303-1a, LYY2022 (SLX5-V5) and SIY778
(slx8D+pJM6864 GAL1p::slx8-4) were maintained in 1%
yeast extract, 2% peptone, 2% dextrose (YPD) or selective
medium as appropriate. Yeast strain construction, growth
and transformation was carried out using standard procedures
(36,37). Mutant alleles of SLX8 were tested by functional
complementation of the synthetic-lethal phenotype of strain
VCY1525 [MATa ade2-1 ade3::hisG ura3-1 his3-11,15
trp1-1 leu2-3,112 lys2 sgs1-20::hphMX4 slx8-10::KAN
pJM500 (URA3/ADE3/SGS1)]. Recombinant proteins were
synthesized in E.coli using the T7 expression system (38)
and the following plasmids: Plasmid pJM6813, which
expresses N-terminally tagged His6-Slx8 protein (Slx8), was
constructed by inserting the SLX8 ORF into plasmid pET28a
on an NdeI–BamHI fragment. Plasmid pJM6818, which
expresses full-length untagged Slx8 protein, was constructed
by inserting the same SLX8 fragment into the NdeI and
BamHI sites of plasmid pET11a. Plasmid pJM6511, which
expresses an N-terminally tagged His6-Slx5 protein (Slx5),
was constructed by inserting the SLX5 ORF into pET28a on
an NdeI–BamHI fragment. The bi-cistonic plasmid pJM6819,
which expresses untagged Slx8 and His6-Slx5 protein (Slx5–
Slx8 complex), was constructed by moving the promoter and
SLX5 ORF of pNJ6511 on a BstEII–BamHI fragment into the
BstEII and BglII sites of pNJ6818.
Expression and purification of recombinant proteins
Recombinant proteins were produced using the T7 expression
system of Studier (38). Plasmids pJM6819 (His6-Slx5 +
Slx8), pJM6813 (His6-SLX8) and pJM6511 (His6-SLX5)
were transformed into E.coli BL21-RIL cells (Stratagene).
Cells with plasmid pJM6819 were grown in Luria–Bertani
(LB) media containing 100 mg/ml ampicillin, whereas
cells with plasmids pJM6813 and pJM6511 were grown in
LB media containing 35 mg/ml kanamycin. Cells were shaken
at 37 Ct oa nO D 600 of 0.4. To induce the expression of the
recombinant protein, cultures were treated with isopropyl-1-
thio-D-galactopyranoside at a ﬁnal concentration of 0.4 mM
overnight at 15 C. Induced cells were pelleted and resus-
pended in Buffer A [25 mM Tris–HCl (pH 7.5), 1 mM
EDTA, 0.01% (v/v) NP-40, 10% glycerol, 0.1 mM phenyl-
methlysulfonyl ﬂuoride (PMSF) and 1 mM DTT] containing
150 mM NaCl and the following protease inhibitors:
10 mg/ml pepstatin, 5 mg/ml leupeptin, 10 mM benzamidine
and 100 mg/ml bacitracin. Extractions and chromatography
were performed at 4 C, except where noted. Cell suspensions
were subjected to three freeze-thaw cycles and then sonicated
three times for 1 min using a Branson soniﬁer 450 microtip at
setting 4, 60% duty cycle. Lysed cells were clariﬁed by cen-
trifugation at 12000 g for 20 min and the supernatant col-
lected as extract. The supernatant was bound to 2 ml of Ni
Probond resin (Invitrogen) in the presence of 10 mM imida-
zole for 2 h, after which the resin was poured into a column.
The column was washed with 10 column volumes (CVs) of
Buffer N [25 mM Tris–HCl (7.5), 500 mM NaCl, 0.01%
NP-40, 10% glycerol and 0.1 mM PMSF] plus 10 mM imida-
zole. The column was developed with 7 CVs of Buffer N plus
50 mM imidazole, 7 CVs of Buffer N plus 100 mM imida-
zole, 7 CVs of Buffer N containing 200 mM imidazole and
5 CVs of Buffer N containing 500 mM imidazole. Peak frac-
tions were identiﬁed by SDS–PAGE and Coomassie blue
staining. The peak fractions were pooled and dialyzed in
Buffer A plus 150 mM NaCl. The Slx5–Slx8 complex was
further puriﬁed by gel-ﬁltration chromatography using a
24 ml Superose 6 HR10/30 column in Buffer A lacking glyc-
erol but containing 150 mM NaCl. Peak Superose 6 fractions
were pooled and subjected to 15–35% glycerol gradient
sedimentation by centrifugation for 24 h at 45 000 r.p.m. in
a Beckman SW55 Ti rotor. Complex stability was tested by
subjecting a portion of the Ni-puriﬁed material to Superose
6 fractionation in the presence of RIPA buffer [150 mM
NaCl, 50 mM Tris–HCl (pH 7.5), 1% (v/v) NP-40, 0.5%
(w/v) deoxycholate and 0.1% (w/v) SDS]. Protein concentra-
tions were determined by the Bradford assay using BSA as
standard.
EMSA assay and DNA substrates
Unless otherwise indicated, Slx5–Slx8 protein was incubated
with 30000 c.p.m.
32P-labeled DNA substrate (5 fmol) in a
ﬁnal volume of 20 ml containing 25 mM HEPES (pH 7.5),
50 mM NaCl, 10 mM ZnSO4, 0.5 mM DTT, 0.1% NP-40,
0.1 mg/ml BSA and 5% glycerol at room temperature (RT)
for 30 min. The reaction products were electrophoresed
through 2.5% polyacrylamide gel (20:1 acrylamide/bis) con-
taining 0.3% agarose and 0.5· Tris–borate–EDTA at 4 C.
The gel was then dried and visualized by a phosphorimager.
All DNA substrates were prepared from labeled oligonu-
cleotides (nt) that were annealed and puriﬁed essentially as
described (22). The oligonucleotides used for this study
were as follows: 1313 (30 nt), TGGCGTTAGGAGATAC-
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GGTATCTCCTAACGCCA; 1315 (45 nt), GGGTCAACGT-
GGGCAAAGATGTCCTAGCAAGCCAGAATTCGGCAG;
1316 (45 nt), CTGCCGAATTCTGGCTTGCTAGGACATC-
TTTGCCCACGTTGACCC; 1317 (90 nt), GATCCGAATT-
CTGGCTTGCTAGGACATCTTTGCCCACGTTGACCCG-
GGTTGGCGTTAGGAGATAGTCAGTTATAGCTGCGGC-
TGCTAAGG; 1319 (90 nt), GATCCCTTAGCAGCCGCAG-
CTATAACTGACTATCTCCTAACGCCAACCCGGGTCA-
ACGTGGGCAAAGATGTCCTAGCAAGCCAGAATTCG;
1312 (15 nt), TATCTCCTAACGCCA; 1320 (15 nt)
TGGCGTTAGGAGATA; 891 (49 nt), ATCGATGTCTCTA-
GACAGCACGAGCCCTAACGCCAGAATTCGGCAGCGT
994 (25 nt), GCTCGTGCTGTCTAGAGACATCGAT; 888
(49 nt), GACGCTGCCGAATTCTGGCGTTAGGAGATAC-
CGATAAGCTTCGGCTTAA; 992 (24 nt), TTAAGCCGA-
AGCTTATCGGTATCT; 1254 (50 nt), TGCCGAATTCTA-
CCAGTGCCAGTGATGGACATCTTTGCCCACGTTGAC-
CC; 1258 (25 nt), ATCACTGGCACTGGTAGAATTCGGC;
1311 (25 nt), TGGGTCAACGTGGGCAAAGATGTCC;
1253 (50 nt), TGGGTCAACGTGGGCAAAGATGTCCTA-
GCAATGTAATCGTCTATGACGTT; 1256 (50 nt), CAA-
CGTCATAGACGATTACATTGCTACATGGAGCTGTCT-
AGAGGATCCGA; 1302 (25 nt), GTCGGATCCTCTAG-
ACAGCTCCATG; 892 (49 nt), GACGCTGCCGAAT-
TCTGGCTTGCTAGGACATCTTTGCCCACGTTGACCC;
893 (50 nt), TGGGTCAACGTGGGCAAAGATGTCC-
TAGCAATGTAATCGTCTATGACGTT; 894 (51 nt),
CAACGTCATAGACGATTACATTGCTAGGACATGCTG-
TCTAGAGACTATCGA; and 895 (50 nt), ATCGATA-
GTCTCTAGACAGCATGTCCTAGCAAGCCAGAATTCG-
GCAGCGT.
Immunological techniques
Puriﬁed recombinant Slx5 and Slx8 proteins were used as
antigens to raise rabbit antisera. To supershift DNA–protein
complexes, EMSAs were performed as above and following
the 30 min incubation, the indicated anti-Slx5, anti-Slx8
and anti-Slx1 sera were added and incubated on ice for
20 min. The products were then resolved by native PAGE
as described above. Yeast immunoﬂuorescence was per-
formed as described previously (39).
Protein chromatin-binding assay and western blotting
Wild-type cells were grown in 50 ml YPD until OD600 ¼ 1.0.
SIY778 cells containing pJM6864 were grown in SD medium
lacking leucine with 2% rafﬁnose to OD 0.2 before induction
with 2% galactose for 6 h. Cells were harvested and sodium
azide was added to 0.1%. Cells were resuspended in 3 ml of
prespheroplasting buffer [100 mM PIPES (pH 9.4) and
10 mM DTT] and incubated at RT for 10 min. This was fol-
lowed by an incubation in 2 ml of spheroplasting buffer
[50 mM KPO4 (pH 7.5), 0.6 M sorbitol and 10 mM DTT],
containing 100 ml of 1 mg/ml of zymolyase (100T) (ICN
Biomedicals, Aurora, OH) in 50 mM KPO4 (pH 7.5) for
20 min at 30 C with occasional mixing. Spheroplasts were
washed, lysed, digested by micrococcal nuclease (MNase)
and fractionated by centrifugation at low or high speeds as
described previously (40). For immunoblotting, proteins
were transferred on to nitrocellulose and blocked with 5%
dry milk in Tris-buffered saline containing 0.1% Tween-20
(TBST). Monoclonal antibodies anti-V5 (Invitrogen) and
anti-Orc5 (a gift from Dr Steve Bell) were used at dilutions
of 1:5000 and 1:1000, respectively. The antiserum against
Slx8 was used at a 1:2000 dilution. Horseradish peroxidase-
coupled anti-mouse secondary antibody (Orc5) and anti-
rabbit secondary antibody (Slx8) was diluted at 1:10 000 in
TBST containing 0.5% dry milk. Reaction products were
visualized with a SuperSignal chemiluminescent reagent
(Pierce).
RESULTS
Purification of Slx5 and Slx8
His6-tagged versions of Slx5 and Slx8 were expressed in
E.coli to produce either Slx5, or Slx8 or the Slx5–Slx8 com-
plex. These proteins were well-expressed and are soluble
allowing for puriﬁcation by Ni–agarose chromatography
(Figure 1A). Slx5 and Slx8 were previously observed to
migrate anomalously in SDS–PAGE when immunoblotted
from yeast extracts (19). As shown in Figure 1A, the recom-
binant proteins showed the same effect where (His6)Slx5
(639 amino acids; pI 7.0; MWcalc ¼ 73 kDa) and (His6)Slx8
(294 amino acids; pI 5.0; MWcalc ¼ 33 kDa) migrated at
MWr ¼ 100 and 69 kDa, respectively. When co-expressed,
the Slx5 and Slx8 proteins appeared to purify as a complex
(Figure 1A). To test this idea, this material was subjected
to gel-ﬁltration chromatography in the presence of 0.15 M
NaCl (Figure 1B and E). This treatment revealed a complex
of Slx5–Slx8 protein and a peak of free Slx5 that had bound
alone to the Ni afﬁnity resin (Figure 1B). In separate
gel-ﬁltration experiments, the Slx5 and Slx8 subunits co-
fractionated even in the presence of 0.1% SDS or 0.5 M
NaCl (data not shown). Thus, the stability of the complex
resembles that observed in yeast cell extracts (19). The
Slx5 and Slx8 proteins also co-sedimented during glycerol
gradient centrifugation (Figure 1C and D). These hydrodyn-
amic data (s ¼ 5.0S; Rs ¼ 48A) yield a native molecular
weight of 106 kDa using the method of Siegel and Monty
(41). This value closely approximates that calculated for a
simple 1:1 complex of (His6)Slx5 and Slx8 (104 kDa). We
conclude that these proteins form a stable heterodimeric
complex.
Slx5–Slx8 binds dsDNA
Slx5–Slx8 complex was tested for DNA-binding activity
using an EMSA. Increasing amounts of protein were incu-
bated with
32P-labeled ssDNA and the free and bound DNA
were resolved by PAGE. As shown in Figure 2A, no inter-
action with ssDNA was apparent. However, binding of
Slx5–Slx8 to dsDNA probes was observed (Figure 2B).
Slx5–Slx8 failed to bind a 15 bp probe, but it bound to probes
of 30 and 45 bp. Thus, the DNA-binding activity of Slx5–
Slx8 requires a substrate of between 15 and 30 bp. A com-
petition experiment was performed to test whether binding
was speciﬁc to the ends of the DNA molecule or to internal
sites. Binding to the 45 bp dsDNA probe could be competed
with either linear (Figure 2C) or circular (Figure 2D) plasmid
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Subunit specificity of Slx5–Slx8
To determine the relative contribution of the two proteins to
DNA-binding activity, we tested the individual subunits of
Slx5–Slx8. As shown in Figure 3A, Slx5 alone showed no
DNA-binding activity by EMSA. In contrast, the isolated
Slx8 subunit was capable of binding the probe on its own.
This result suggests that Slx8 is the main DNA-binding
subunit. When the two subunits were incubated together
with probe, Slx5 appeared to have little or no effect on the
DNA-binding activity of Slx8. In contrast to this result, puri-
ﬁed Slx5–Slx8 complex was capable of binding similar
amounts of probe at  10-fold lower protein concentrations.
In this experiment,  8 pmol of Slx8 was required for half-
maximal DNA binding, whereas only 0.5 pmol of Slx5–
Slx8 bound most of the probe (Figure 3A). The fact that
Slx5 and Slx8 are more active when puriﬁed as a complex
suggests that reconstitution of the complex does not occur
efﬁciently in vitro. Taken together, these results suggest
Figure 1. Purification and characterization of recombinant Slx5–Slx8 complex. Slx5 and Slx8 were expressed either individually or together in E.coli and
purified by chromatography on Ni–agarose as described in Materials and Methods. (A) Approximately 1 mg (His6)Slx8, 1 mg (His6)Slx5 and 2 mg (His6)Slx5–
Slx8 complex were resolved by 12.5% SDS–PAGE and subjected to Coomassie blue staining. (B) An aliquot of 150 mg of the Ni-purified complex was subjected
to Superose 6 size exclusion chromatography and analyzed as in (A). The positions of (His6)Slx5 (100 kDa) and Slx8 (69 kDa) subunits are indicated. Lanes: M,
MW marker; L, Column Load. (C) The Slx5–Slx8 complex (Superose 6 pool) was subjected to 15–35% glycerol gradient sedimentation and fractions analyzed as
above. Also shown are the sedimentation (D) and gel-filtration (E) profiles of the Slx5–Slx8 complex relative to the indicated standards.
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however, we cannot rule out the possibility that these samples
differ in the fraction of active molecules present in the two
preparations.
We next tested whether or not both subunits were present
in the DNA–protein complexes formed with Slx5–Slx8. In
this experiment we ﬁrst incubated the 45 bp probe with
Slx8 and then added increasing amount of antiserum directed
against Slx5 or Slx8. As shown in Figure 3B, the Slx8 protein
shifted the 45 bp probe as before and was unaffected by
anti-Slx5 serum. In contrast, the anti-Slx8 serum produced
a progressive retardation, or supershift, of Slx8–DNA com-
plexes. A control serum against Slx1 protein was inactive
in supershifting this complex. Gel-shifted complexes with
Slx5–Slx8 were treated similarly. When incubated with
increasing amounts of anti-Slx5 serum, the DNA–protein
complex was gradually supershifted until it remained in the
well (Figure 3C). Similarly, increasing amounts of anti-Slx8
caused a supershifting of these protein–DNA complexes
(Figure 3C) whereas the control serum against Slx1 had no
effect. We conclude that Slx5–Slx8 binds DNA as a complex
with both subunits present in the protein–DNA complex.
Substrate specificity of Slx5–Slx8
Other proteins identiﬁed in SGS1-synthetic-lethal screens
have been shown to have structure-speciﬁc DNA endo-
nuclease activity (42,43). To see if the Slx5–Slx8 complex
preferred to bind branched substrates, we examined the sub-
strate speciﬁcity of Slx5–Slx8 using a variety of radiolabeled
substrates. As shown in Figure 4, Slx5–Slx8 bound to all
dsDNA substrates tested including branched and nicked
forms with no signiﬁcant difference in afﬁnity. As expected
for a simple DNA-binding activity, larger dsDNA substrates
(e.g. 45 and 90 bp) were bound at lower protein concentra-
tions than the smaller 30 bp substrate (Figure 4A–C). This
preference is presumably due to a greater availability of bind-
ing sites. Consistent with this idea, the use of a 90 bp dsDNA
probe revealed a second lower-mobility band at higher pro-
tein concentrations. This second band-shift suggests that the
Figure 2. Slx5–Slx8 binds dsDNA by gel-mobility shift assay. (A) An aliquot of 5 fmol of a 49 nt radiolabeled ssDNA oligonucleotide was incubated with either
E.coli SSB (0, 0.014, 0.7 or 1.4 pmol) or Slx5–Slx8 (0, 0.01, 0.6 or 1.2 pmol) prior to EMSA. Protein–DNA complexes were resolved by 2.5% polyacrylamide/
0.3% agarose gel electrophoresis and analyzed by phosphorimaging. The positions of Slx5–Slx8/DNA complexes (Bound) or unbound substrate (Free) are
indicated. The asterisk indicates 50-
32P-labeling of the probes. (B) An aliquot of 5 fmol of the indicated dsDNA probe was incubated with Slx5–Slx8 (0, 1.2, 2.45
or 4.9 pmol) before EMSA. (C) Gel-mobility shift assays were performed using 4 pmol Slx5–Slx8, 5 fmol of a 45 bp duplex probe and increasing amounts of
linearized unlabeled competitor plasmid DNA (3.2 kb). (D) Gel-mobility shift assays were performed as in (C) but the competitor plasmid was undigested. The
substrates were assembled from the following oligonucleotides: *888 (49 nt); *1312/1320 (15 bp); *1313/1314 (30 bp); and *1315/1316 (45 bp).
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not possible using smaller DNAs. Incubation of Slx5–Slx8
with these substrates in the presence of Mg
2+ failed to reveal
endonuclease activity (data not shown).
We tested the role of Zn in DNA binding by modifying
the proteins’ cysteine residues with the reversible reagent
p-Hydroxymercuriphenylsulfonate (PMPS) (44). Covalent
modiﬁcation of cysteine residues by PMPS results in the
release of Zn in a reaction that is often reversible by treatment
with the reducing agent DTT in the presence of Zn (44).
Although the DNA-binding activity of Slx5–Slx8 was inacti-
vated by PMPS, we were unable to restore activity by subse-
quent treatment with DTT and increasing amounts of Zn (data
not shown). Because PMPS treatment was not informative,
we performed a structure–function analysis to map the
DNA-binding domain.
The role of the Zn-binding motif in Slx8 function was
conﬁrmed by functional analysis in yeast. DNA sequencing
of the original slx8-1 allele revealed a single missense muta-
tion, C221Y, that targets the third conserved cysteine residue
in the RING-ﬁnger sequence C3HC4 (Figure 5A). Thus,
the RING-ﬁnger motif of Slx8 appears to be critical for func-
tion in vivo. To conﬁrm this idea, we created additional
RING-ﬁnger mutations, as well as truncations of the N- and
C-termini of Slx8. One hypomorphic allele, slx8-2 (C221S),
was identiﬁed that conferred a slow-growth phenotype in
the sgs1 mutant background, while an allele that altered
three conserved RING domain residues (slx8-3) appeared
null in vivo (Figure 5B). In contrast, truncation of the
N-terminal 163 residues of Slx8 conferred a slight
growth defect. Truncation of all residues N-terminal to the
RING domain generated an allele that was also viable
(slx8-5), but even more slow-growing in the sgs1 background
(Figure 5B). The slx8-4 and slx8-5 alleles lacked the
HU-sensitivity of slx8 null mutants (data not shown).
These results indicate that the RING domain is essential
for in vivo function and that the N-terminus of Slx8 is largely
dispensible for viability in this assay. Interestingly, Slx8
lacking the RING domain fails to bind Slx5 in a recombinant
expression system (data not shown). This suggests that
dimer formation may be essential for in vivo function.
To localize the DNA-binding domain of Slx8, we expressed
and puriﬁed these six mutant proteins (Figure 5C). As shown
in Figure 5D, mutations in RING domain had no effect on
the ability of Slx8 to bind DNA, although deletion of the
N-terminus (Slx8-4 and Slx8-5 proteins) eliminated this
activity. The N-terminal domain was sufﬁcient for binding
as the Slx8-6 protein bound the probe with an afﬁnity similar
to wild-type Slx8.
In vivo localization of Slx5–Slx8
The DNA-binding activity of Slx5–Slx8 implies a role in
the yeast nucleus. A nuclear function is also suggested by
the genetic redundancy between Slx5–Slx8 and the Sgs1–
Top3–Rmi1 complex. We tested this idea by immunolocaliz-
ing Slx5 within yeast cells using a strain that expresses
epitope-tagged Slx5 under its own promoter. Treatment of
these cells with anti-V5 monoclonal antibody resulted in
speciﬁc nuclear staining that was present in unbudded and
Figure 3. Slx8 is responsible for the DNA-binding activity of the Slx5–Slx8 complex. (A) An aliquot of 5 fmol of
32P-labeled dsDNA (45 bp) was incubated
with indicated amounts of Slx5, Slx8, Slx5 and Slx8 mixed together (Slx5 + Slx8), or Slx5–Slx8 (Complex) followed by EMSA analysis. (B and C) Supershift
analysis was performed to identify proteins present in the protein–DNA complex. A total of 32 pmol of Slx8 (B) or 8 pmol of Slx5–Slx8 complex (C) were
incubated with 5 fmol of
32P-labeled dsDNA (45 bp). The reaction products were then incubated with anti-Slx5, anti-Slx8 or anti-Slx1 serum as indicated,
followed by EMSA analysis.
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punctate. This result indicates that a signiﬁcant proportion of
Slx5 protein resides in the nucleus and that localization is
independent of cell-cycle position.
We next tested the prediction that Slx8 bound chromatin
in vivo by immunoblotting chromatin fractions that had been
isolated by differential centrifugation (40). Upon lysis of cell
spheroplasts, the majority of Slx8 protein was observed to
fractionate with the soluble pool; however, a portion was
also found in the pellet (Figure 7, upper panel). This frac-
tionation differs from that of Orc5, which is found mostly
in the pellet fraction (Figure 7, lower panel) as described
originally in (40). If Slx8 was bound to chromatin it should
be solubilized by treatment of the chromatin with MNase.
As shown in Figure 7, lane 4, MNase treatment solubilized
all the Slx8 material and a majority of the Orc5 material.
These solubilized fractions were then subjected to high-
speed centrifugation to test whether the liberated proteins
were bound to polynucleosomes. As shown in lane 7, a
small fraction of the Slx8 and all of the Orc5 pelleted
under these conditions. The pelleted Slx8 material was not
simply due to precipitation of the soluble protein since
high-speed centrifugation of the initial soluble pool (fraction
2) was unable to pellet any Slx8 protein (Figure 7, lanes 8 and
9). Chromatin fractionation was also carried out on cells
expressing the Slx8-4 protein that lacks DNA-binding activ-
ity. In order to overcome the difﬁculty of detecting this small
protein on immunoblots we overexpressed Slx8-4 using the
GAL1 promoter. Although Slx8-4 protein was again mostly
soluble (fraction 2), we were surprised to ﬁnd a strong signal
in the polynucleosome fraction (Figure 7, middle panel).
These results suggest that Slx5–Slx8 binds to chromatin
even in the absence of the Slx8 DNA-binding domain. Such
behavior is consistent with the ability of slx8-4 to largely
complement the slx8 mutant phenotype and suggests that
Slx8 may interact with other DNA-bound proteins. Such
interactions are known to exists in ORC, for example,
where subunits such as Orc3 fractionate with chromatin but
do not contact DNA directly (40,45). Taken together, these
results indicate that a portion of the Slx8 protein fractionates
with chromatin and that this fractionation is independent of
its DNA-binding domain.
Figure 4. Structure-independent DNA binding of Slx5–Slx8. Increasing amounts of purified Slx5–Slx8 (0, 0.1, 0.25, 0.5, 1, 2, 4, 8 or 16 pmol) were incubated
with 5 fmol of the indicated 50-
32P-labeled substrates and analyzed as in Figure 2: (A) 30 bp blunt-ended dsDNA, (B) 45 bp dsDNA, (C) 90 bp dsDNA,
(D) dsDNA with 30-extension, (E) Y structure, (F)5 0-flap, (G) nicked duplex, (H) nicked Holliday junction and (I) Holliday junction. The substrates
were assembled from the following oligonucleotides: (A) *1313/1314, (B) *1315/1316, (C) *1317/1319, (D) *891/994, (E) *891/888, (F) *891/888/992,
(G) *1254/1258/1311, (H) *1254/1253/1256/1258/1302 and (I) *892/893/894/895.
Nucleic Acids Research, 2006, Vol. 34, No. 19 5547Figure 5. Structure–function analysis of Slx5–Slx8. (A) Schematic diagram of the wild-type and mutant Slx8 proteins indicating the conserved RING-finger
residues. (B) Strain VCY1525 (sgs1D slx8D), which contains the complementing plasmid pJM500 (SGS1/URA3), was first transformed with centromere-based
vector (pRS415) or vector containing the indicated SLX8 allele. Complementation of slx8D phenotype was then tested by serial dilution and spotting onto media
containing 5-FOA to select against pJM500 or onto media lacking leucine as control. (C) An aliquot of 2 mg of the indicated Slx8 protein was resolved by SDS–
PAGE and stained with Coomassie blue. (D) The indicated Slx8 protein (0, 0.4, 1.2 and 4 pmol) was incubated with 5 fmol of the 45 bp 50-
32P-labeled substrate
and analyzed using EMSA as in Figure 2.
Figure 6. Slx5 is a nuclear protein. Spheroplasted yeast cells of the indicated genotype were incubated with anti-V5 antibodies and processed for microscopy
using differential interference contrast (DIC) and epifluorescence (EPI). The following strains were used: LYY2022 (SLX5-V5) and W303-1a (SLX5).
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The major conclusion from this work is that recombinant
Slx5 and Slx8 form a stable complex that interacts with DNA.
Although previous studies have observed physical interac-
tions between Slx5 and Slx8, those experiments employed
proteins that were overexpressed and did not address whether
the Slx5–Slx8 interaction was direct (19,46). Here we have
shown that the recombinant Slx5–Slx8 complex is stable to
chromatography in the presence of 0.5 M NaCl or 0.1%
SDS. Even though this interaction suggests that they act as
a complex in vivo, it is still unknown whether Slx5 and
Slx8 are bound together at all times in vivo, or if they have
other binding partners. This will require chromatographic
fractionation of soluble yeast extracts to quantitatively mea-
sure their co-fractionation and to determine the composition
of Slx5–Slx8 complexes in vivo. At present, we have
shown that Slx5 and Slx8 are predominantly nuclear.
The Slx8 subunit appears to be responsible for the DNA-
binding activity of the complex, although we cannot rule out
a role for Slx5. Supershift analysis indicates that both sub-
units are present in the DNA-bound complex. And although
Slx5 did not improve the binding of Slx8 when the two pro-
teins had been puriﬁed individually, the puriﬁed complex
bound DNA  10-fold more efﬁciently than Slx8 alone.
Thus, it is possible that Slx5 stimulates the DNA-binding
activity of Slx8 in the complex. Such a cooperative interac-
tion might also explain why the Slx8-4 protein, lacking its
DNA-binding domain, still fractionated with chromatin. Our
inability to reconstitute the Slx5–Slx8 complex in vitro from
its individual subunits is reminiscent of other multi-subunit
complexes (e.g. Mus81–Mms4, Slx1–Slx4 and RPA) that
are assembled only when co-expressed in vivo (42,43,47).
The DNA-binding activity of Slx5–Slx8 is likely to be
biologically relevant for several reasons. First, SLX5 and
SLX8 were originally identiﬁed based on a genetic interaction
with SGS1-TOP3, which encodes a protein complex that acts
during recombination-mediated DNA repair. Second, both
proteins have been shown to play a role in maintaining gen-
ome stability [(25) and Janet R. Mullen and Steven J. Brill,
unpublished data] and both proteins immunolocalize to
the nucleus. Finally, DNA binding is speciﬁc for dsDNA
>15 bp with no preference for DNA structures that mimic
recombinational intermediates. Although we cannot rule out
the possibility that we did not test the optimal substrate, the
data are most consistent with the idea that the complex binds
dsDNA without any regard to structure or sequence. In chro-
matin fractionation experiments Slx8 behaved differently
than a stable sequence-speciﬁc DNA-binding protein, Orc5,
in that only a small fraction of it was bound to chromatin
fragments. Thus, Slx8 appears to be a largely soluble protein
that may bind DNA in a speciﬁc phase of the cell cycle, in
response to DNA damage, or it may have additional activities
that are independent of DNA.
The DNA-binding domain of Slx8 was localized to the
N-terminal 200 amino acids, which does not include the
RING ﬁnger. Amino acid sequence alignments of Slx8
homologs from a variety of yeast species have not revealed
obvious conserved motifs in this region (19). As a result,
more speciﬁc mutational analysis will be required to pinpoint
the domain that directly interacts with DNA. Although the
N-terminus is dispensible for yeast viability in the absence
of SGS1, sgs1D cells containing N-terminal truncation alleles
were slightly slow-growing. We suspect that this hypomor-
phic phenotype arises from the loss of DNA binding of this
protein; however, it is possible that the N-terminus plays a
role in maintaining the structure of the RING domain, in
binding Slx5, or in some other Slx8 function. Genetic charac-
terization of the alleles lacking the N-terminus should address
these questions and provide clues as to the biological function
of the DNA-binding domain.
The major unanswered question in this work concerns the
mechanism by which Slx5–Slx8 controls genome stability.
The fact that Slx5 and Slx8 both contain RING-ﬁnger motifs
suggests the possibility that they have the same or related
enzyme activity. And the strong physical interaction between
these two proteins may explain why mutations in either SLX5
or SLX8 produce nearly identical phenotypes (19,20,25). One
possibility that is being pursued relates to the fact that a large
number of RING-ﬁnger proteins function as ubiquitin or
SUMO E3 ligases. Although recent studies have revealed
genetic interactions between SLX5-SLX8 and components of
the sumoylation pathway (20), we have been unsuccessful
in demonstrating a RING-dependent Ub or SUMO E3 ligase
activity for either protein (Tatsuya Ii, Janet R. Mullen and
Steven J. Brill, unpublished data). If Slx5–Slx8 does the func-
tion as a Ub or SUMO E3 ligase, it may be possible that Slx5
and Slx8 are mutually dependent or have some overlap in
function in one of these pathways. Given this possibility,
the DNA-binding activity of Slx8 may be involved in target-
ing Slx5 to the DNA where it could modify chromatin pro-
teins or perform some other function. Clearly, it will be
necessary to determine the enzymatic activity of Slx5 before
we fully understand the role of this complex in controlling
genome stability.
Figure 7. A portion of Slx8 protein is bound to chromatin. Wild-type
or GAL1p::slx8-4 yeast cells were lysed and the resulting extracts were
fractionated by differential centrifugation and MNase treatment. Fractions
were then immunoblotted for Slx8 (upper two panels) or Orc5 (lower
panel) as follows: (1) whole cell extract; (2) first low-speed supernatant
containing non-chromatin-binding proteins; (3) crude chromatin pellet; (4)
polynucleosome-containing supernatant after limited MNase digestion of
fraction 3; (5) chromatin pellet remaining after MNase digestion of fraction 3;
(6) soluble proteins from polynucleosomes following ultracentrifugation of
fraction 4; (7) pelleted polynucleosomes following ultracentrifugation of
fraction 4; (8) soluble proteins following ultracentrifugation of fraction 2; and
(9) insoluble proteins following ultracentrifugation of fraction 2. Immuno-
blotted material was normalized by loading cell equivalents in each lane.
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